ملخصات أفضل الممارسات

guidance for Investors

Our Best Practice Briefs are the standing record of how we think about, and encourage others to run, commercial diligence: the questions that recur across our work, the failure modes we see repeated, and the analytical frames that hold up across sectors and cycles. We publish these because the discipline is better when we are able to align with our clients and more of the field practices it well. Drawn from more than twenty years of work, the Briefs are written to be used, on your own deals, by your own teams, not just read.

The Briefs are not a side project. They are where our thinking is worked out and written down, and the same thinking runs through every engagement we take, every market we cover, and every conversation we have with an investor. When a question recurs across deals, it becomes a Brief; when a Brief proves out in the field, it sharpens the next engagement. The library is the record of that loop, and the reason our work is consistent from one deal to the next.

If you would like to share your thoughts on our ideas, please don’t hesitate to reach out to us.

View all Best Practices By
48 insight found |

041: Taking Price Seriously in Commercial Due Diligence (CDD) Mandates

يُعدّ استخدام التسعير كأداة ضغط أمرًا بالغ الأهمية، ومع ذلك، غالبًا ما يُغفل عنه ويُستهان به كجزء من عملية التدقيق. قبل عدة سنوات، قامت إحدى كبرى شركات الاستشارات المالية للشركات بـ...

044: تحليل الميزة التنافسية في التدقيق التجاري يتنبأ بأداء الاستثمار

تكاد تكون مزاعم الميزة التنافسية في مذكرات الاستثمار وأهداف الاستحواذ عالمية - ومع ذلك، على الرغم من القوة المؤكدة للمزايا الاقتصادية في تحديد عوائد الاستثمار ودفعها، فإن معظم عمليات التدقيق التجاري النافي للجهالة ...

- تحميل -
Learn More

الأمور الحديثة

Read about selected transactions where Matters Graph advised its clients with Buy-Side Commercial Due Diligence.

Diligence Matters: Investor Toolkit

A proven Commercial Due Diligence process to execute better deals proven commercial due diligence process to execute better deals.